Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C: design, development, and place in therapy
Thomas G Cotter,1 Donald M Jensen21Center for Liver Diseases, The University of Chicago Medicine, Chicago, IL, USA; 2Section of Hepatology, RUSH University Medical Center, Chicago, IL, USAAbstract: Direct-acting antiviral (DAA) therapy has changed the landscape of hepatitis C virus (HCV) management...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | |
| Опубликовано: |
Dove Medical Press,
2019-07-01T00:00:00Z.
|
| Предметы: | |
| Online-ссылка: | Connect to this object online. |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Internet
Connect to this object online.3rd Floor Main Library
| Шифр: |
A1234.567 |
|---|---|
| Копировать 1 | Доступно |